Synapse News
OmniaBio announces $90M from private investor: CCRM’s capabilities go from clinical to commercial scale
OmniaBio, a subsidiary of CCRM, has executed a strategic agreement with Medipost, a global leader in stem cell therapeutics. Medipost is acquiring an interest in OmniaBio from CCRM for cash of $30 million and is investing an additional $60 million into OmniaBio. OmniaBio will start construction at McMaster Innovation Park this summer, an
Able Innovations announces $7.5 million to take the pain out of patient transfer
Able Innovations operates in a space that Dr. Gaurav Puri, chief of Newmarket, Ontario-based Southlake Regional Health Centre’s emergency department, describes as “not particularly sexy.” The Toronto-based robotic medical device startup focuses on the problem of patient transfer—a run-of-the-mill, labour-intensive procedure that
Able Innovations announces $7.5 million to take the pain out of patient transfer
The Toronto-based robotic medical device startup (and Innovation Factory HEALTHI program participant) focuses on the problem of patient transfer—a run-of-the-mill, labour-intensive procedure that usually involves some combination of porters, nurses, and orderlies lifting a patient from point a to point b, sometimes using bed sheets or a
McMaster entrepreneur (Synmedix) uses baking soda to supercharge antibiotic
It was by chance that McMaster University professor Eric Brown found a possible solution to the growing problem of antibiotic resistance: bicarbonate. Now, helped by $300,000 from the seed fund sponsored by McMaster’s vice-president, research, his start-up firm Synmedix will soon test a new topical preparation of bicarbonate mixed with the
Nowhere to grow:Canada’s biotech sector is booming, but a lack of lab space has some companies looking south (subscription required)
Laboratories—whether wet, where chemicals, drugs and biological matter can be tested and analyzed; or dry, with a focus on computers, electronics and other such instruments—can’t operate just anywhere. According to Daniel Lacey, practice lead for life sciences at real estate services firm CBRE in Toronto, they need specialized
Ontario Together Fund Supports NERv Technology’s Domestic Manufacturing
hrough the Ontario Together Fund, the Ontario provincial government has committed $559,200 to support the domestic manufacturing and commercialization of NERv Technology’s breakthrough post-operative monitoring solutions as part of the company’s $1.118 million investment. NERv Technology Inc. is a Kitchener-based medical device
$20 million investment will improve access to high-quality care for families in Hamilton
Ontario Building a Stronger, More Resilient Hamilton Health Sciences As part of its plan stay open, the Ontario government is investing over $20 million to modernize Hamilton Health Sciences. This funding will support planning for the redevelopment of Juravinski Hospital and Cancer Centre and the expansion of Hamilton General Hospital’s
Two Hamilton innovators win national Arthritis Ideator Awards
Two Hamiltonians were among 4 winners (and eight finalists) in a national competition which provides funding for innovative projects that help people suffering from arthritis. The Arthritis Ideator Program — run by the Arthritis Society — received 21 submissions from innovators, entrepreneurs, and startups across Canada working on
McMaster Seed Fund supports two startups in first round of funding with $735,000
Two McMaster startups – Syndemix and Insight Medbotics – have received a combined $735,000 to move their innovations closer to reality in the first round of investments of the McMaster Seed Fund. Synmedix — a biotechnology company founded by Eric Brown, Distinguished University Professor of biochemistry and biomedical sciences —